Resilient MetLife stock holds firm after strong Q2 2026 earnings beat

MetLife Inc. (ISIN US59156R1086) stock is trading in a tight range around $96.66 on August 13, 2026, as investors digest a solid second-quarter 2026 earnings beat and updated profit outlook that point to continued earnings growth into late 2026. On the same date, the shares moved between $96.29 and $97.12, leaving the current price fractionally above the intraday low and slightly below the session high per a recent market-data overview.

Q2 2026 earnings beat supports valuation

In early August 2026, MetLife Inc. reported second-quarter 2026 revenue of $19,154 million, providing a broad picture of its global insurance and retirement operations for the three months ended in June 2026. Per an earnings summary, net income for the same quarter reached $736 million, underscoring that the group remained clearly profitable at mid-year 2026.

More important for equity investors, MetLife reported second-quarter 2026 adjusted operating earnings of $1.6 billion, which translated into adjusted earnings per share of $2.43. The EPS figure compares favorably with a consensus that had expected roughly $2.30 per share for Q2 2026, meaning the company delivered a positive earnings surprise of 5.6 percent on this key metric. The double-digit 15 percent year-over-year increase in adjusted EPS for Q2 2026 illustrates that profit growth is running ahead of the modest revenue expansion.

A separate research review of MetLife’s first-quarter calendar 2026 performance reinforces that the recent earnings strength is not an isolated event. For Q1 2026, revenue was reported at $19.07 billion, representing 1.3 percent growth year over year, while adjusted EPS of $2.42 exceeded analyst estimates of $2.27 by 6.6 percent. That earlier beat, combined with the Q2 2026 upside surprise, suggests MetLife has now delivered two consecutive quarters of mid-single-digit EPS beats versus Wall Street expectations in 2026.

Consensus expectations and valuation context

Forward-looking estimates show that analysts expect MetLife’s earnings momentum to continue. For the quarter ending in September 2026, the consensus calls for EPS of $2.55, which implies an 8.97 percent year-over-year increase compared with the same quarter of 2025. That growth rate, if achieved, would mark a further acceleration from the Q2 2026 year-over-year EPS increase of 15 percent on an already elevated base.

Extending the horizon, Wall Street anticipates full-year EPS of $9.30 for MetLife over the next twelve months, a figure that equates to 7.6 percent expected growth. Taken together, the Q2 2026 beat and the forward estimates suggest that the company’s earnings trajectory is on a steady upward path, even as revenue growth remains modest in the low single digits.

Valuation metrics help investors frame these earnings expectations in price terms. A detailed research note puts MetLife’s share price at $84.82 in late June 2026 and indicates that this level corresponds to a forward price-to-book ratio of 2 times, a multiple that some observers view as demanding relative to the company’s revenue profile. However, more recent quote data on August 13, 2026, place the stock at $96.66, with a market capitalization reported at $62.21 billion and a price-to-earnings ratio of 18.52. The stock also carries a dividend yield of 2.37 percent, adding direct cash returns to the total shareholder profile.

The relationship between the current trading level and analyst price targets provides another quantified comparison. One research compilation notes that analysts have a consensus one-year price target of $92 on MetLife when the share price was $84.82, implying upside of 8.5 percent from that earlier level. A more recent set of projections aimed at investors outside the United States points to a target price of $102.25 and identifies a 5.47 percent upside compared with a current price of $96.66, reflecting that while the stock has already advanced materially, expected gains from here are more moderate.

Share-price behavior in August 2026

Intraday trading data on August 13, 2026, show MetLife stock moving within a fairly narrow corridor. A live-quote snapshot records the shares at $96.66, with the day’s range running from a low of $96.29 to a high of $97.12. That leaves the equity trading 0.4 percent above its intraday low and 0.5 percent below the session peak, a pattern consistent with consolidation after the recent earnings release rather than an aggressive breakout move.

Looking at the most recent completed regular trading session, market portals list MetLife’s closing price at $96.68 on August 12, 2026, equivalent to a modest decline of 0.12 percent on the day. Another news overview for the same date cites a closing price of $96.56, down 0.25 percent, with extended trading lifting the quote to $96.83, up 0.28 percent. These slight discrepancies in reported closing ticks reflect minor data rounding and timestamp differences across portals but converge on the picture of a stock that has been essentially flat, oscillating in a tight band around the mid-$90s in recent sessions.

From a broader perspective, MetLife’s share price during 2026 has moved higher compared with levels earlier in the year. The research report that referenced a price of $84.82 and a market capitalization of $51.72 billion showed the stock trading meaningfully below the current mid-$90s level in late June 2026. With the market cap now cited at $62.21 billion, investors can see that the company’s equity value has expanded by roughly $10.5 billion in less than two months, helped by the combination of earnings beats and a supportive rate backdrop for insurers.

Institutional ownership and dividend profile

Institutional investors play a large role in MetLife’s shareholder structure. An ownership breakdown indicates that 94.99 percent of the company’s stock is held by institutions, such as mutual funds, pension funds, and other large professional investors. This high level of institutional participation tends to underpin trading liquidity and can moderate volatility as long-term holders weigh fundamental developments rather than short-term headlines.

Income-oriented investors also pay attention to MetLife’s dividend stream. The current dividend yield of 2.37 percent, based on the share price around August 13, 2026, provides a tangible cash return that compares with yields on broader equity indices and certain fixed-income instruments. Given the mid-single-digit expected earnings growth rate and the company’s position as a major life insurer and retirement-services provider, the combination of yield and growth underpins a total-return profile that many investors find attractive in a diversified portfolio.

Consensus data for upcoming earnings further frame expectations. Schedules compiled by market research teams show that MetLife is expected to report third-quarter 2026 results on November 4, 2026, with the same date appearing in several earnings calendars. For Q3 2026, estimate trends put the current consensus at $2.54 per share, unchanged from one month and three months earlier, indicating that analysts have not materially revised their views since the second-quarter report.

MetLife’s core insurance and retirement products

MetLife is best known for its broad suite of life insurance and retirement products, which together anchor its revenue base and support its long-term earnings power. The company’s portfolio spans individual life policies, group life coverage offered through employers, and various savings and investment-linked contracts designed to help policyholders accumulate assets over time.

In the retirement and employee-benefits arena, MetLife offers annuities, pension-risk transfer solutions, and disability and dental benefits that corporations and public-sector entities use to support their workforce. These products generate recurring premium income and fee revenue, which in turn fund the investment portfolio that backs policyholder obligations and drives net investment income.

One representative product type is the suite of annuity offerings that provide guaranteed income streams for retirees. These contracts can be structured to pay fixed amounts for a set number of years or for the lifetime of the annuitant, with optional features such as inflation protection or survivor benefits. The attractiveness of annuities tends to increase in environments where interest rates are relatively high and customers seek stable, predictable cash flows for their retirement years.

As of mid-2026, MetLife’s reported revenue and earnings figures for the second quarter indicate that demand for its core products remains resilient. The Q2 2026 revenue of $19,154 million spans premium income and other fee-based revenue, while the $736 million in net income and $2.43 adjusted EPS show that the company is successfully balancing underwriting results and investment performance. For investors, the dynamics of these product lines, including the balance between traditional protection products and more capital-light fee businesses, are an important part of the longer-term valuation discussion.

MetLife stock and current market value

With MetLife stock trading around $96.66 on August 13, 2026, the shares are quoted less than one dollar away from the recent intraday high of $97.12 and roughly 12 dollars above the late-June level of $84.82 cited in earlier research. The current market capitalization of $62.21 billion and the 18.52 price-to-earnings ratio define the valuation investors are paying for the insurer’s mid-single-digit revenue growth, mid- to high-single-digit earnings growth, and 2.37 percent dividend yield.

For equity investors, these numbers offer a concrete framework: the share price reflects a balance between the strength of recent earnings beats, the stability of the insurance and retirement businesses, and the relatively full valuation implied by a 2 times forward price-to-book ratio. How MetLife executes against its Q3 2026 EPS consensus of $2.55 and the full-year $9.30 earnings expectation will determine whether the current valuation multiple remains justified or needs to be revisited.

Read more

Further details on MetLife’s latest earnings and strategic initiatives are available in the company’s own investor materials and detailed third-party research, which elaborate on segment performance, capital management, and regulatory developments.

Fact box

Company: MetLife Inc.

ISIN: US59156R1086

Ticker: MET

Exchange: NYSE

Price (as of August 13, 2026): $96.66 USD

Market cap: $62.21 billion (as of August 13, 2026)

Sector / Industry: Financials / Insurance

Index membership: S&P 500

Next earnings date: November 4, 2026